Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Differentiated Thyroid Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 1760 Neoplasms 1259 Carcinoma, Non-Small-Cell Lung 1139 Prostatic Neoplasms 946 Multiple Myeloma 731 Leukemia, Myeloid, Acute 653 Neoplasm Metastasis 617 Colorectal Neoplasms 612 Lung Neoplasms 595 Melanoma 582 Lymphoma 565 Leukemia 511 Lymphoma, Non-Hodgkin 495 Leukemia, Lymphocytic, Chronic, B-Cell 459 Ovarian Neoplasms 459 Pancreatic Neoplasms 436 Precursor Cell Lymphoblastic Leukemia-Lymphoma 412 Recurrence 401 Carcinoma, Renal Cell 359 Myelodysplastic Syndromes 359 Lymphoma, Follicular 358 Head and Neck Neoplasms 339 Glioblastoma 335 Brain Neoplasms 331 Lymphoma, Large B-Cell, Diffuse 320 Carcinoma, Hepatocellular 293 Hodgkin Disease 291 Squamous Cell Carcinoma of Head and Neck 269 Lymphoma, Mantle-Cell 264 Sarcoma 244

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01843062 2019-08-28

ASTRA

AstraZeneca

Phase 3 Terminated

233 enrolled 14 charts

EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡